{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T06:05:38Z","timestamp":1778393138734,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ymgme.2018.07.012","type":"journal-article","created":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T17:55:48Z","timestamp":1532368548000},"page":"168-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Prolonged treatment with open-label pirfenidone in Hermansky-Pudlak syndrome pulmonary fibrosis"],"prefix":"10.1016","volume":"125","author":[{"given":"Kevin J.","family":"O'Brien","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy J.","family":"Introne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orhan","family":"Akal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tulay","family":"Akal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9548-7872","authenticated-orcid":false,"given":"Adrian","family":"Barbu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa P.","family":"McGowan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa A.","family":"Merideth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Samuel L.","family":"Seward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William A.","family":"Gahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernadette R.","family":"Gochuico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2018.07.012_bb0005","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1056\/NEJM199804303381803","article-title":"Genetic defects and clinical characteristics of patients with a form of oculocutaneous albinism (Hermansky-Pudlak syndrome)","volume":"338","author":"Gahl","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2018.07.012_bb0010","series-title":"GeneReviews\u00ae [Internet]","article-title":"Hermansky-Pudlak Syndrome. 2000 Jul 24 [Updated 2017 Oct 26]","author":"Huizing","year":"1993"},{"key":"10.1016\/j.ymgme.2018.07.012_bb0015","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/ng1196-300","article-title":"Positional cloning of a gene for Hermansky-Pudlak syndrome, a disorder of cytoplasmic organelles","volume":"14","author":"Oh","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2018.07.012_bb0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1097-2765(00)80170-7","article-title":"Altered trafficking of lysosomal proteins in Hermansky-Pudlak syndrome due to mutations in the beta 3A subunit of the AP-3 adaptor","volume":"3","author":"Dell'Angelica","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymgme.2018.07.012_bb0025","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/ng576","article-title":"Mutation of a new gene causes a unique form of Hermansky-Pudlak syndrome in a genetic isolate of central Puerto Rico","volume":"28","author":"Anikster","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2018.07.012_bb0030","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ng835","article-title":"Hermansky-Pudlak syndrome is caused by mutations in HPS4, the human homolog of the mouse light-ear gene","volume":"30","author":"Suzuki","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2018.07.012_bb0035","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/ng1087","article-title":"Ru2 and Ru encode mouse orthologs of the genes mutated in human Hermansky-Pudlak syndrome types 5 and 6","volume":"33","author":"Zhang","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2018.07.012_bb0040","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/ng1229","article-title":"Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1)","volume":"35","author":"Li","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2018.07.012_bb0045","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1086\/499338","article-title":"A germline mutation in BLOC1S3\/reduced pigmentation causes a novel variant of Hermansky-Pudlak syndrome (HPS8)","volume":"78","author":"Morgan","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2018.07.012_bb0050","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1182\/blood-2012-01-404350","article-title":"Exome sequencing reveals a pallidin mutation in a Hermansky-Pudlak-like primary immunodeficiency syndrome","volume":"119","author":"Badolato","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2018.07.012_bb0055","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1182\/blood-2015-09-671636","article-title":"Mutations in AP3D1 associated with immunodeficiency and seizures define a new type of Hermansky-Pudlak syndrome","volume":"127","author":"Ammann","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2018.07.012_bb0060","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1378\/chest.117.1.129","article-title":"Pulmonary function and high-resolution CT findings in patients with an inherited form of pulmonary fibrosis, Hermansky-Pudlak syndrome, due to mutations in HPS-1","volume":"117","author":"Brantly","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.ymgme.2018.07.012_bb0065","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00439-003-0933-5","article-title":"Hermansky-Pudlak syndrome type 4 (HPS-4): clinical and molecular characteristics","volume":"113","author":"Anderson","year":"2003","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2018.07.012_bb0070","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3324\/haematol.2009.012286","article-title":"Two patients with Hermansky-Pudlak syndrome type 2 and novel mutations in AP3Ba","volume":"95","author":"Wenham","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.ymgme.2018.07.012_bb0075","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2119\/molmed.2011.00198","article-title":"Interstitial lung disease and pulmonary fibrosis in Hermansky-Pudlak syndrome-2, an AP-3 complex disease","volume":"18","author":"Gochuico","year":"2012","journal-title":"Mol. Med."},{"key":"10.1016\/j.ymgme.2018.07.012_bb0080","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13023-018-0780-z","article-title":"Hermansky-Pudlak syndrome type 2 manifests with fibrosing lung disease early in childhood","volume":"13","author":"Hengst","year":"2018","journal-title":"Orphan. J. Rare Dis."},{"key":"10.1016\/j.ymgme.2018.07.012_bb0085","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.healun.2004.11.015","article-title":"Successful bilateral lung transplantation for pulmonary fibrosis associated with the Hermansky-Pudlak syndrome","volume":"24","author":"Lederer","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ymgme.2018.07.012_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194193","article-title":"Clinical barriers to lung transplantation in Hermansky-Pudlak syndrome pulmonary fibrosis","volume":"13","author":"El-Chemaly","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2018.07.012_bb0095","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S1096-7192(02)00044-6","article-title":"Effect of pirfenidone on the pulmonary fibrosis of Hermansky-Pudlak syndrome","volume":"76","author":"Gahl","year":"2002","journal-title":"Mol. Gen. Metabol."},{"key":"10.1016\/j.ymgme.2018.07.012_bb0100","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ymgme.2011.02.003","article-title":"Pirfenidone for the treatment of Hermansky-Pudlak syndrome pulmonary fibrosis","volume":"103","author":"O'Brien","year":"2011","journal-title":"Mol. Gen. Metabol."},{"key":"10.1016\/j.ymgme.2018.07.012_bb0105","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(11)60405-4","article-title":"Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials","volume":"377","author":"Noble","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2018.07.012_bb0110","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2018.07.012_bb0115","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1159\/000479976","article-title":"An open-label study of the long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosis (RECAP)","volume":"94","author":"Costabel","year":"2017","journal-title":"Respiration"},{"key":"10.1016\/j.ymgme.2018.07.012_bb0120","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2015-000105","article-title":"Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trials","volume":"3","author":"Lancaster","year":"2016","journal-title":"BMJ Open Respir. Res."},{"key":"10.1016\/j.ymgme.2018.07.012_bb0125","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/archinternmed.2007.59","article-title":"Progressive preclinical interstitial lung disease in rheumatoid arthritis","volume":"168","author":"Gochuico","year":"2008","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ymgme.2018.07.012_bb0130","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1378\/chest.10-2545","article-title":"Quantification of HRCT scan findings in individuals at risk for pulmonary fibrosis","volume":"140","author":"Rosas","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.ymgme.2018.07.012_bb0135","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2214\/ajr.179.4.1790887","article-title":"Hermansky-Pudlak syndrome: radiography and CT of the chest compared with pulmonary function tests and genetic studies","volume":"179","author":"Avila","year":"2002","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.ymgme.2018.07.012_bb0140","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1164\/rccm.200901-0023OC","article-title":"Alveolar macrophage dysregulation in Hermansky-Pudlak syndrome type 1","volume":"180","author":"Rouhani","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ymgme.2018.07.012_bb0145","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1542-3565(05)00858-X","article-title":"Intestinal disease in Hermansky-Pudlak syndrome: occurrence of colitis and relation to genotype","volume":"4","author":"Hussain","year":"2006","journal-title":"Clin. Gastroenterol. Hepatol."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719218303093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719218303093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T14:22:27Z","timestamp":1604672547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719218303093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":29,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1096719218303093"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2018.07.012","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prolonged treatment with open-label pirfenidone in Hermansky-Pudlak syndrome pulmonary fibrosis","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2018.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}